Making sense of Operation TrialBlazer: What’s in HHS’s research reform plan

By Ned Pagliarulo and Laura DiAngelo, MPH

HHS has unveiled Operation TrialBlazer, a broad initiative intended to strengthen U.S. clinical research through coordinated actions across the FDA, NIH and other federal health agencies. The roadmap brings together numerous ongoing and proposed efforts aimed at streamlining early-stage development, improving trial infrastructure and increasing research competitiveness.

While many of the FDA policies highlighted were already underway, the initiative provides new context for how the agency’s guidance, pilot programs and future rulemaking fit into a broader research modernization strategy.

This AgencyIQ analysis breaks down the roadmap’s major policy initiatives and what they could mean for sponsors, clinical researchers and future FDA regulatory priorities.

Fill out the form to read the full analysis.